Novo Nordisk Lilly Shares Slump on Price-Cut Loom Plans
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Identify the mix that offers broader exposure for retirement by comparing Sp500 and total market allocations and adjusting for risk.
28,595 articlesNews of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
A security researcher leveraged Claude-powered tooling to reveal a long-standing vulnerability in Zcash's Orchard cir...
Zillow marks its 20th anniversary this month with a bold AI push to reinvent every step of the homebuying journey, fr...
Gordon Ritter argues that AI’s learning loop isn’t a job-killer countdown, but a shift toward human-driven innovation...
Fintech players are quietly testing AI-driven payments with stablecoins as a potential alternative to card rails, sig...
Retirees are flocking to Clorox as the market bets on continued high yields. The company offers a compelling 5.5% div...
As renewed scrutiny of Jeffrey Epstein's network surfaces, investors and philanthropists face reputational risk that ...
Whatnot has crossed a historical milestone: one billion orders processed on its live-commerce platform, fueling a $11...
Iran tensions and hawkish policy signals are lifting yields, putting mortgage rates breaking higher and spring housin...
A new poll finds 89% of registered voters backing the main provisions of the ROAD Act, even as the bill remains stall...
When a company’s stock doubles and an insider sells a large block, investors should ask: what’s really going on? This...
A quirky NYC art project turned a moment of hype into a budgeting lesson. Discover how a $25 'Pocket Garbage' cube sp...